Clinical Trial Update: Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating the efficacy and safety of Psirelax for mild-to-moderate psoriasis. The study was sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Psirelax

Snippet

Sponsor: Etwal Ltd. | Conditions: Mild to Moderate Psoriasis | Phase 2 | Status: COMPLETED